WHO Drug Information Vol. 20, No. 4, 2006 - World Health ...
WHO Drug Information Vol. 20, No. 4, 2006 - World Health ...
WHO Drug Information Vol. 20, No. 4, 2006 - World Health ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Proposed INN: List 96 <strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong>, <strong>Vol</strong>. <strong>20</strong>, <strong>No</strong>. 4, <strong>20</strong>06<br />
296<br />
C<strong>20</strong>H15F2NO<br />
F<br />
F<br />
O<br />
NH 2<br />
289656-45-7<br />
sergliflozinum<br />
sergliflozin 2-[(4-methoxyphenyl)methyl]phenyl 6-O-(ethoxycarbonyl)-<br />
β-D-glucopyranoside<br />
antidiabetic<br />
sergliflozine 6-O-(éthoxycarbonyl)-β-D-glucopyranoside de 2-[(4-méthoxyphényl)=<br />
méthyl]phényle<br />
antidiabétique<br />
sergliflozina 6-O-(etoxicarbonil)-β-D-glucopiranósido de 2-[(4-metoxifenil)=<br />
metil]fenilo<br />
hipoglucemiante<br />
C23H28O9<br />
H 3C<br />
O<br />
O<br />
O O O<br />
HO<br />
OH<br />
OH<br />
OCH 3<br />
408504-26-7<br />
tanespimycinum<br />
tanespimycin (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-<br />
4,10,12,16-tetramethyl-3,<strong>20</strong>,22-trioxo-19-[(prop-2-en-1-yl)amino]-<br />
2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate<br />
antineoplastic<br />
tanespimycine carbamate de (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-<br />
8,14-diméthoxy-4,10,12,16-tétraméthyl-3,<strong>20</strong>,22-trioxo-19-[(prop-<br />
2-én-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18pentaén-9-yle<br />
antinéoplasique<br />
tanespimicina carbamato de (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hidroxi-<br />
8,14-dimetoxi-4,10,12,16-tetrametil-3,<strong>20</strong>,22-trioxo-19-[(prop-2-en-<br />
1-il)amino]-2-azabiciclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-ilo<br />
antineoplásico